Pharma-Bio Serv (PBSV) Cash & Equivalents Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 17.04% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 5.55% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 11.52% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 13.84% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 10.47% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | -19.91% |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | -7.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -7.26% |
| Oct 31, 2025 | -38.41% |
| Jul 31, 2025 | -34.74% |
| Apr 30, 2025 | -45.82% |
| Jan 31, 2025 | -21.92% |
| Oct 31, 2024 | -27.10% |
| Jul 31, 2024 | -26.61% |
| Apr 30, 2024 | -39.78% |
| Jan 31, 2024 | -30.36% |
| Oct 31, 2023 | -15.21% |
| Jul 31, 2023 | -44.53% |
| Apr 30, 2023 | -19.61% |
| Jan 31, 2023 | -22.05% |
| Oct 31, 2022 | -2.26% |
| Jul 31, 2022 | -1.27% |
| Apr 30, 2022 | -5.16% |
| Jan 31, 2022 | -0.95% |
| Oct 31, 2021 | 2.91% |
| Jul 31, 2021 | 2.95% |
| Apr 30, 2021 | 7.54% |
| Jan 31, 2021 | 13.25% |
| Oct 31, 2020 | 13.92% |
| Jul 31, 2020 | 11.29% |
| Apr 30, 2020 | 7.04% |
| Jan 31, 2020 | 3.72% |
| Oct 31, 2019 | 3.99% |
| Jul 31, 2019 | 1.84% |
| Apr 30, 2019 | 2.27% |
| Jan 31, 2019 | 2.86% |
| Oct 31, 2018 | 2.48% |
| Jul 31, 2018 | 2.58% |
| Apr 30, 2018 | -3.57% |
| Oct 31, 2017 | -8.41% |
| Oct 31, 2016 | 4.57% |
| Apr 30, 2016 | 19.32% |
| Jan 31, 2016 | 27.45% |
| Oct 31, 2015 | 31.58% |
| Jul 31, 2015 | 40.72% |
| Apr 30, 2015 | 53.60% |
| Oct 31, 2014 | 51.76% |
| Oct 31, 2013 | 73.23% |